Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)

Sinphar Pharmaceutical Revenue

Sinphar Pharmaceutical had revenue of 805.59M TWD in the quarter ending March 31, 2025, with 3.63% growth. This brings the company's revenue in the last twelve months to 3.18B, up 7.06% year-over-year. In the year 2024, Sinphar Pharmaceutical had annual revenue of 3.15B with 6.33% growth.

• Revenue (ttm): 3.18B
• Revenue Growth: +7.06%
• P/S Ratio: 1.86
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.91B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.15B	187.69M	6.33%
Dec 31, 2023	2.96B	106.28M	3.72%
Dec 31, 2022	2.86B	423.14M	17.39%
Dec 31, 2021	2.43B	45.06M	1.89%
Dec 31, 2020	2.39B	-6.14M	-0.26%